Triathlon Tritanium Cone Augments Outcomes Study

Inclusion Criteria: * Patient has signed an Institutional Review Board (IRB)/Ethics Committee (EC) approved, study specific Informed Patient Consent Form. * Patient is a male or non-pregnant female, skeletally mature and age 18 years or older at time of study device implantation. * Patient is a candidate for revision of all femoral and tibial components of a total knee replacement. * Patient is willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation. Exclusion Criteria: * Patient has a Body Mass Index (BMI) \> 45. * Patient has an active or suspected latent infection in or about the affected knee joint at time of study device implantation. * Patient has a neuromuscular or neurosensory deficiency, which limits the ability to evaluate the safety and efficacy of the device. * Patient is diagnosed with a systemic disease (e.g. Lupus Erythematosus) or a metabolic disorder (e.g. Paget's disease) leading to progressive bone deterioration. * Patient is immunologically suppressed or receiving steroids in excess of normal physiological requirements (e.g. \> 30 days). * Patient has a failed unicondylar knee prosthesis. * Patient has a known sensitivity to device materials. * Patient is a prisoner.